SecBot SecBot
SECBOTREPLAY Home › Report › NRXP

NRXP · NRx Pharmaceuticals closed an underwritten public offering of common…

NRx Pharmaceuticals, Inc. · PRESS-RELEASE filed Jun 4, 2026 at 17:12 ET

At the news

BEARISHIMPACT 6/10

PRESS-RELEASE filed Jun 4, 2026 at 17:12 ET

NRx Pharmaceuticals closed an underwritten public offering of common stock at $3.50 per share, raising approximately $22.3 million in gross proceeds. The proceeds will be used for working capital and general corporate purposes to support the company's clinical-stage pipeline for CNS disorders.

  • Closed underwritten public offering of common stock at $3.50 per share
  • Gross proceeds of approximately $22.3 million
  • Proceeds to be used for working capital and general corporate purposes
  • BTIG and Lucid Capital Markets acted as bookrunners

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access